» Authors » C Vandebrouck

C Vandebrouck

Explore the profile of C Vandebrouck including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 14
Citations 219
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Pascarel K, Colas J, Mirval S, Becq F, Vandebrouck C
Rev Mal Respir . 2023 Feb; 40(3):230-233. PMID: 36775781
Cystic fibrosis is a disease caused by a mutation on the CFTR gene coding for a chloride channel. The dominant mutation F508del eliminates the CFTR protein at the surface of...
2.
Chatauret N, Coudroy R, Delpech P, Vandebrouck C, Hosni S, Scepi M, et al.
Am J Transplant . 2014 Oct; 14(11):2500-14. PMID: 25307148
Protection of endothelial cell function may explain the benefits of nonoxygenated hypothermic machine perfusion (MP) for marginal kidney preservation. However, this hypothesis remains to be tested with a preclinical model....
3.
Norez C, Vandebrouck C, Bertrand J, Noel S, Durieu E, Oumata N, et al.
Br J Pharmacol . 2014 Jul; 171(21):4831-49. PMID: 25065395
Background And Purpose: The most common mutation in cystic fibrosis (CF), F508del, causes defects in trafficking, channel gating and endocytosis of the CF transmembrane conductance regulator (CFTR) protein. Because CF...
4.
Ouedraogo M, Da F, Fabre A, Konate K, Dibala C, Carreyre H, et al.
Evid Based Complement Alternat Med . 2013 May; 2013:162651. PMID: 23710211
Aqueous-ethanolic extract of Cassia alata (AECal) and its derived fractions obtained through liquid-liquid fractionation were evaluated for their bronchorelaxant, genotoxic, and antigenotoxic effects. Contractile activity of rats' tracheas in the...
5.
Ouedraogo M, Ruiz M, Vardelle E, Carreyre H, Coustard J, Potreau D, et al.
J Ethnopharmacol . 2010 Oct; 133(2):345-52. PMID: 20937377
Aim Of The Study: Effects of the different fractions obtained by partition of ethanolic extract (EE) of Agelanthus dodoneifolius through column chromatography were investigated on rat blood pressure and aortic...
6.
Bertrand J, Boucherle B, Billet A, Melin-Heschel P, Dannhoffer L, Vandebrouck C, et al.
Eur Respir J . 2010 Jan; 36(2):311-22. PMID: 20110398
One of the major therapeutic strategy in cystic fibrosis aims at developing modulators of cystic fibrosis transmembrane conductance regulator (CFTR) channels. We recently discovered methylglyoxal alpha-aminoazaheterocycle adducts, as a new...
7.
Sebille S, Cantereau A, Vandebrouck C, Balghi H, Constantin B, Raymond G, et al.
Comput Methods Programs Biomed . 2005 Jan; 77(1):57-70. PMID: 15639710
In muscle cells, force development is controlled by Ca2+ ions, which are rapidly released from the sarcoplasmic reticulum (SR) during sarcolemmal depolarization. In addition to this synchronized spatially homogeneous calcium...
8.
Squire S, Raymackers J, Vandebrouck C, Potter A, Tinsley J, Fisher R, et al.
Hum Mol Genet . 2002 Dec; 11(26):3333-44. PMID: 12471059
Duchenne muscular dystrophy results from the absence of dystrophin, a cytoskeletal protein. Previously, we have shown in a transgenic mouse model of the disease (mdx) that high levels of expression...
9.
De Backer F, Vandebrouck C, Gailly P, Gillis J
J Physiol . 2002 Aug; 542(Pt 3):855-65. PMID: 12154184
Skeletal muscles of the mdx mouse lack dystrophin offering the possibility to study the role of intracellular Ca(2+) ions in fibre degeneration. Flexor digitorum brevis muscles of 3-month-old mdx and...
10.
Imbert N, Vandebrouck C, Duport G, Raymond G, Hassoni A, Constantin B, et al.
J Physiol . 2001 Jul; 534(Pt. 2):343-55. PMID: 11454955
1. The goal of the present study was to investigate differences in calcium movements between normal and Duchenne muscular dystrophy (DMD) human contracting myotubes co-cultured with explants of rat spinal...